TYRA Tyra Biosciences, Inc.
Healthcare$33.29+0.00%OpenMarket Cap: $1.98B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$50.50
Target (Median)
$51.50
Target Range
$42.00 - $59.00
Upside from current price: 51.7%
Rating Distribution
2 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-20 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-17 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-13 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-03 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-03 | Jefferies | maintain | Buy | Buy |
| 2026-01-23 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-16 | Wedbush | maintain | Outperform | Outperform |
| 2025-08-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-01 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.85 | $7.2M | 10 |
| Sun Dec 31 | $-3.04 | $9.2M | 8 |
| Mon Dec 31 | $-2.96 | $54.3M | 6 |
| Tue Dec 31 | $-1.40 | $228.4M | 6 |